Assessment of the inhibitory effects of different radiation qualities or chemotherapeutic agents on a human melanoma cell line

Physica Medica

Volumn 24, Issue 4, 2008, Pages 187-195

  Ristić Fira, Aleksandra M ^a   Petrović, Ivan M ^a   Korićanac, Lela B ^a   Valastro, Lucia M ^b   Privitera, Giuseppe ^c   Cuttone, Giacomo ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b INFN SEZIONE DI CATANIA   (Italy)

^c Istituto di Radiologia   (Italy)

Author keywords

Rays; Alkylating agents; Cellular sensitivity; HTB140 melanoma cells; Protons

Indexed keywords

DACARBAZINE; FOTEMUSTINE; SULFORHODAMINE B;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CLONOGENIC ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS RESISTANCE; CYTOTOXICITY; DOSE RESPONSE; GAMMA RADIATION; HUMAN; HUMAN CELL; MELANOMA; PROTON RADIATION; RADIOSENSITIVITY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MELANOMA; RADIATION DOSAGE;

EID: 55549121213     PISSN: 11201797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejmp.2008.04.002     Document Type: Article

References (27)

1. Courdi A., Caujolle J.-P., Grange J.-D., Diallo-Rosier L., Sahel J., Bacin F., et al. Results of proton therapy of uveal melanomas treated in Nice. Int J Radiat Oncol Biol Phys 45 (1999) 5-11
2. Egger E., Zografos L., Schalenbourg A., Beati D., Böhringer T., Chamot L., et al. Eye retention after proton beam radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys 55 4 (2003) 867-880
3. Kinnaert E., Morandini R., Simon S., Hill H.Z., Ghanem G., and Van Houtte P. The degree of pigmentation modulates the radiosensitivity of human melanoma cells. Radiat Res 154 (2000) 497-502
4. Belli M., Bettega D., Calzolari P., Cera F., Cherubini R., Dalla Vecchia M., et al. Inactivation of human normal and tumour cells irradiated with low energy protons. Int J Radiat Biol 76 6 (2000) 831-839
5. Green L.M., Murray D.K., Tran D.T., Bant A.M., Kazarians G., Moyers M.F., et al. Response of thyroid follicular cells to gamma irradiation compared to proton irradiation. I. Initial characterization of DNA damage, micronucleus formation, apoptosis, cell survival, and cell cycle phase redistribution. Radiat Res 155 (2001) 32-42
6. Petrović I., Ristić-Fira A., Todorović D., Valastro L., Cirrone P., and Cittone G. Radiobiological analysis of human melanoma cells on the 62 MeV CATANA proton beam. Int J Radiat Biol 82 4 (2006) 251-265
7. Soengas M.S., and Lowe S.W. Apoptosis and melanoma chemoresistance. Oncogene 22 (2003) 3138-3151
8. 6-methylguanine DNA-methyltransferase expression. J Pharmacol Exp Ther 307 2 (2003) 816-823
9. Rünger T.M., Emmert S., Schadendorf D., Diem C., Epe B., and Hellfritsch D. Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine or etoposide. J Invest Dermatol 114 (2000) 34-39
10. Jungnelius U., Ringborg U., Aamdal S., Mattsson J., Stierner U., Ingvar C., et al. Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial. Eur J Cancer 34 9 (1998) 1368-1374
11. Grossman D., and Altieri D.C. Drug resistance in melanoma: mechanisms, apoptosis, and new potential therapeutic targets. Cancer Metastasis Rev 20 (2001) 3-11
12. Pauwels B., Korst A.E.C., De Pooter C.M.J., Pattyn G.G.O., Lambrechts H.A.J., Baay M.F.D., et al. Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies. Cancer Chemother Pharmacol 51 (2003) 221-226
13. Griffon G., Merlin J.-L., and Marchal C. Comparison of sulforhodamine B, tetrazolium and clonogenic assays for in vitro radiosensitivity testing in human ovarian cell lines. Anti-Cancer Drugs 6 (1995) 115-123
14. Price P., and McMillan T.J. Use of the tetrazolium assay in measuring the response of human tumor cells to ionizing radiation. Cancer Res 50 (1990) 1392-1396
15. Petrović I., Korićanac L., Todorović D., Ristić-Fira A., Valastro L., Privitera G., et al. Viability of a human melanoma cell after single and combined treatment with fotemustine, dacarbazine and proton irradiation. Ann NY Acad Sci 1095 (2007) 154-164
16. Korićanac L., Petrović I., Privitera G., Cuttone G., and Ristić-Fira A. HTB140 melanoma cells under proton irradiation and/or drug treatment. Russ J Phys Chem 9 (2007) 1467-1470
17. Absorbed dose determination in external beam radiotherapy: an international code of practice for dosimetry based on standards of absorbed dose to water. In: IAEA Technical Report Series No. 398. Vienna: IAEA; 2000. p. 135-150.
18. Cirrone G.A.P., Cuttone G., Lojacono P.A., Lo Nigro S., Mongelli V., Patti I.V., et al. A 62 MeV proton beam for the treatment of ocular melanoma at Laboratori Nazionali del Sud-INFN. IEEE Trans Nucl Sci 51 3 (2004) 860-865
19. GEANT4: detector description and simulation tool. CERN Program Library; 1998.
20. 3H]thymidine incorporation and soft agar clonogenic assays. Eur J Cancer 30A 9 (1994) 1370-1376
21. Daşu A., and Denekamp J. Inducible repair and intrinsic radiosensitivity: a complex but predictable relationship?. Radiat Res 153 (2000) 279-288
22. Rodrigez-Vincente J., Vicente-Ortega V., and Canteras-Jordana M. The effects of different antineoplastic agents and of pretreatment by modulators on three melanoma lines. Cancer 82 3 (1998) 495-502
23. Shibuya H., Kato Y., Masuyoshi S., Isobe T., Tsuboi R., Koga M., et al. Induction of apoptosis and/or necrosis following exposure to antitumour agents in a melanoma cell line, probably through modulation of Bcl-2 family proteins. Melanoma Res 13 (2003) 457-464
24. Sanada M., Takagi Y., Ito R., and Sekiguchi M. Killing and mutagenic actions of dacarbazine, a chemotherapeutic alkylating agent, on human and mouse cells: effects of Mgmt and Mlh1 mutations. DNA Repair 3 (2004) 413-420
25. Raaphorst G.P., Wang G., Wilkins D., Davis L., Bussey A., Stewart D., et al. Evaluation of cisplatin response in three radiation resistant and three radiation sensitive cell lines. Anticancer Res 14 (1994) 1939-1942
26. Kumala S., Niemiec P., Widel M., Hancock R., and Rzeszowska-Wolny J. Apoptosis and clonogenic survival in three tumour cell lines exposed to gamma rays or chemical genotoxic agents. Cell Mol Biol Lett 8 (2003) 655-665
27. 6-methylguanine-DNA methyltransferase by glucose-conjugated inhibitors: comparison with nonconjugated inhibitors and effect on fotemustine and temozolomide-induced cell death. J Pharmacol Exp Ther 311 2 (2004) 585-593